AUSTIN, Texas, Dec. 7, 2011 /PRNewswire/ -- Medicare carrier Palmetto GBA is proposing new processes that govern how it will handle code stack claims for molecular diagnostic tests (MDT) and laboratory-developed tests (LDT) in the J1 region, to become effective on February 27, 2012. This marks the first known effort by a payer to address specific problems caused when laboratories submit code stacked claims for genetic tests and molecular diagnostics assays.
These important developments will be covered in a special audio conference to be conducted on Tuesday, December 20, 2012, by The Dark Report & Darkdaily.com. Featured speakers from Palmetto GBA are: Elaine Jeter, M.D., Medical Director; and Mike Barlow, Vice President. Jeter and Barlow will discuss five important subjects:
This audio conference is an open public forum which allows every laboratory professional to hear these presentations and participate in the question and answer session that follows. It is also an opportunity for lab consultants and experts in genetic and molecular testing to hear, first-hand, the details behind the two proposed LCDs and MolDx, the proposed Molecular Diagnostic Services Program.
This high-value, low-cost 90-minute audio conference is of critical interest to laboratories performing molecular diagnostic tests and lab-developed tests. As noted above, Palmetto GBA executives will directly address the issues of concern to laboratory leaders to be caused by the growing number of code-stacked claims. In addition, the executives will answer specific questions from the audience during a phone Q&A. Media representatives who would like to listen to this audio conference should email Justin M. Clark at: 512-264-7103.
THE DARK REPORT (www.darkreport.com) invites you to participate in this important and timely new audio conference. For more information or to register, call toll-free: 800-560-6363
For additional information, Contact: Justin M. Clark, 512-264-7103
|SOURCE THE DARK REPORT|
Copyright©2010 PR Newswire.
All rights reserved